Cardinal Health takes $3.9bn leap into specialty healthcare with two key acquisitions

Cardinal Health takes $3.9bn leap into specialty healthcare with two key acquisitions

In a bold move to expand its reach in specialty healthcare, Cardinal Health has announced it will acquire significant assets in gastroenterology and diabetes care through two high-stakes deals worth a combined $3.9 billion. The U.S.-based pharmaceutical and healthcare giant is set to take a controlling interest in GI Alliance, the largest independent gastroenterology care […]

Eli Lilly completes $3.2 billion acquisition of Morphic to enhance IBD treatments

Eli Lilly completes $3.2 billion acquisition of Morphic to enhance IBD treatments

Eli Lilly and Company has finalised its acquisition of Morphic Holding, Inc. in a landmark $3.2 billion deal, aimed at enhancing treatment options for inflammatory bowel disease (IBD). This acquisition underscores Lilly’s strategic expansion into the gastroenterology sector. The transaction, valued at $57 per share, is a significant premium over Morphic’s recent stock prices, reflecting […]

Takeda’s $62bn acquisition of Shire: A game-changing move for global pharma

Takeda’s $62bn acquisition of Shire: A game-changing move for global pharma

In a landmark deal, Takeda Pharmaceutical Company has successfully completed its previously announced acquisition of Shire, an Irish biotech leader specializing in rare diseases, for a staggering $62 billion. This acquisition marks a major step in Takeda’s ongoing transformation into a global powerhouse in biopharmaceuticals, with an expanded footprint and a deeper focus on rare […]

Norgine expands presence in Germany with new office opening in Wettenberg

Norgine expands presence in Germany with new office opening in Wettenberg

Dutch pharmaceutical giant Norgine has inaugurated new offices in Wettenberg, Germany, marking a significant step in its ongoing growth strategy. This move strengthens its commitment to its largest product sales market, where it has been a key player since 1928. The new facility is set to enhance the company’s operations and support services, ensuring the […]

Takeda Pharmaceutical set to acquire TiGenix for €520m, enhancing gastroenterology and specialty care offerings

Takeda Pharmaceutical set to acquire TiGenix for €520m, enhancing gastroenterology and specialty care offerings

Japanese pharmaceutical giant Takeda Pharmaceutical has announced a proposal to acquire TiGenix, a Belgium-based cell therapy company, for €520 million. This acquisition is aimed at expanding Takeda’s late-stage gastroenterology portfolio and enhancing its presence in the American specialty care market. TiGenix, established in 2000, specializes in the development of novel treatments for serious medical conditions […]